Evidence map›Paper›PMID 37762317›Full record

ArticleInternational journal of molecular sciences2023

Rhamnolipid 89 Biosurfactant Is Effective against

Erica Tambone, Chiara Ceresa, Alice Marchetti, Silvia Chiera, Adriano Anesi, Giandomenico Nollo, Iole Caola, Michela Bosetti, Letizia Fracchia, Paolo Ghensi and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Erica TamboneDepartment of Industrial Engineering & BIOtech, University of Trento, 38123 Trento, Italy.
Chiara CeresaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy.
Alice MarchettiDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy.ORCID 0000-0001-8673-5769
Silvia ChieraDepartment of Industrial Engineering & BIOtech, University of Trento, 38123 Trento, Italy.
Adriano AnesiDepartment of Laboratory Medicine, Azienda Provinciale per i Servizi Sanitari, 38122 Trento, Italy.ORCID 0000-0002-1744-6127
Giandomenico NolloDepartment of Industrial Engineering & BIOtech, University of Trento, 38123 Trento, Italy.ORCID 0000-0002-9837-083X
Iole CaolaDepartment of Laboratory Medicine, Azienda Provinciale per i Servizi Sanitari, 38122 Trento, Italy.
Michela BosettiDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy.ORCID 0000-0002-3682-8702
Letizia FracchiaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy.ORCID 0000-0003-3505-1919
Paolo GhensiDepartment CIBIO, University of Trento, 38123 Trento, Italy.ORCID 0000-0002-8444-0489
Francesco TessaroloDepartment of Industrial Engineering & BIOtech, University of Trento, 38123 Trento, Italy.ORCID 0000-0003-4022-5602
University of Trento · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

European Union-Fondo Sociale Europeo Recovery Assistance for Cohesion and the Territories of the European Union (FSE-REACT-EU) Programma Operativo Nazionale (PON), Azione IV.4 - Research and Innovation, DM 1062/2021Fondazione Cassa di Risparmio di Trento e Rovereto Grant for young researchers involved in excellence research projects, ref. n 2017.0340SIdP (Italian Society of Periodontology and Implantology), Firenze, Italy Call Periodontology/Implant Dentistry 2016Università degli Studi del Piemonte Orientale Bando Fondazione CRT, Id. 393
6 · The paper itself

Abstract

Biofilm-related peri-implant diseases represent the major complication for osteointegrated dental implants, requiring complex treatments or implant removal. Microbial biosurfactants emerged as new antibiofilm coating agents for implantable devices thanks to their high biocompatibility. This study aimed to assess the efficacy of the rhamnolipid 89 biosurfactant (R89BS) in limiting

Indexed as

Anti-Bacterial AgentsBiofilmsDental ImplantsGlycolipidsOsteoblastsStreptococcus oralisSurface-Active AgentsBacterial AdhesionCell AdhesionCell DifferentiationCell ProliferationCells, CulturedHumansTitaniumAnti-Bacterial AgentsDental ImplantsGlycolipidsrhamnolipidSurface-Active AgentsTitaniumantibiofilm activitybiocompatibilitydental implantsdislodging actionmicrobial biosurfactantsmucositisosteoblastsperi-implantitisrhamnolipidstitanium

Identifiers

PMID37762317
PMCPMC10530769
OpenAlexW4386723328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.